Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

OECD - Organisation for Economic Co-operation and : Health spending in Europe falls for the first time in decades

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/16/2012 | 12:51pm CEST

16/10/12-  Health spending fell across the European Union in 2010, as cash-strapped governments curbed outlays to help cut budgetary deficits, according to Health at a Glance: Europe 2012, a new joint report by the OECD and the European Commission.

This drop in spending per person and as a percentage of GDP reverses increases seen in the years before the economic crisis, when health spending per person grew two or three times faster than incomes in many countries.  From an annual average growth rate of 4.6% between 2000 and 2009, health spending per capita fell to -0.6% in 2010.  This is the first time health spending has fallen in Europe since 1975.

In Ireland, health spending fell 7.9% in 2010, compared with an average annual growth rate of 6.5% between 2000 and 2009. In Estonia, health expenditure per person dropped by 7.3% in 2010, following growth of over 7% per year from 2000 to 2009, with reductions in both public and private spending.  In Greece, estimates suggest that health spending per person fell 6.7% in 2010, reversing annual growth of 5.7% between 2000 and 2009.

The report cautions that the reduction or slowdown in spending in nearly all EU countries may have a long-term impact on health care outcomes.



Source: Health at Glance: Europe 2012 (based on OECD Health Data 2012; Eurostat Statistics Database; WHO Global Health Expenditure Database).

Spending on disease prevention accounts for only 3% of total health spending

Governments, under pressure to protect funding for acute care, are cutting other expenditures such as public health and prevention programmes. In 2010, on average across EU countries, only 3% of health budgets was allocated to prevention and public health programmes in areas such as immunisation, smoking, alcohol drinking, nutrition and physical activity. The report notes that spending on prevention now can be much more cost-effective than treating diseases in the future.

More than half of adults in the European Union are now overweight, and 17% are obese.  Obesity rates have doubled since 1990 in many European countries, and now range from 8% in Romania and Switzerland to over 25% in Hungary and the United Kingdom. Obesity and smoking are the major risk factors for heart disease and stroke which accounted for over one-third (36%) of all deaths across EU countries in 2010.

Finland, France and Hungary have recently introduced taxes on unhealthy food and drink as part of their efforts to counter obesity.  These "fat taxes" are designed to change eating habits, while at the same time generating public revenues that may be used to support other public health and prevention programmes.

The OECD and European Commission's Health at a Glance: Europe 2012 presents key indicators of health status, determinants of health, health care resources and activities, quality of care, health expenditure and financing in 35 European countries, including the 27 EU member states, 5 candidate countries and 3 EFTA countries.

Other findings from the report include:

  • Health spending as a share of GDP was highest in the Netherlands (12%) in 2010, followed by France and Germany (11.6%).  The share of GDP allocated to health was 9.0% on average across EU countries, down from 9.2% in 2009.

  • Doctors:  Despite concerns of shortages, the number of doctors per capita has increased in almost all EU member states over the past decade from an average 2.9 per 1 000 population in 2000 to 3.4 in 2010. Growth was particularly rapid in Greece and the United Kingdom.

  • Generalist/Specialist balance: There are now many more specialists than GPs in nearly all countries due to lack of interest in traditional "family medicine" practice and a growing remuneration gap. The slow growth or reduction in generalists raises concerns about access to primary care for certain population groups.

To know more

The electronic version of the report is available at:

http://www.oecd.org/health/healthataglanceeurope.htm

http://ec.europa.eu/health/reports/european/

For more information contact:

Mark Pearson (+33 1 45 24 92 69 or mark.pearson@oecd.org), OECD Health Division

Gaétan Lafortune (+33 1 45 24 92 67 or gaetan.lafortune@oecd.org), OECD Health Division

Frederic Vincent  (+ 32 229 87166 or Frederic.VINCENT@ec.europa.eu), European Commission

Follow the discussion on Twitter using #OECDHealth

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news
Date Title
05:41a VERIZON : Customers Can Connect With Friends and Family in Turkey for Free Following Istanbul Airport Attacks
05:35a WYNDHAM WORLDWIDE : Vacation Ownership Invites You To “Show Your Travel Side”
05:35a RGA – REPUBLICAN GOVERNORS ASSOCIATION : Statement on the Utah Gubernatorial Primary
05:32a SUZUKI MOTOR : Motors says Brexit to have 'major' impact on earnings
05:31a PHILIPPINE STOCK EXCHANGE : Vista Land, UP tie up to develop Silicon Valley model
05:30a ZENITH BANK : Court won't defreeze Fayose's account
05:30a DELEGATION OF EUROPEAN UNION TO CHINA : Commissioner Arias Cañete in China for G20 energy ministerial and bilateral cooperation
05:30a Golden Haven marks stock market debut
05:30a PHILIPPINE STOCK EXCHANGE : PSEi down anew as Brexit worries linger
05:30a RESOLUTION NOTICE OF THE 76TH ANNUAL GENERAL MEETING OF SHAREHOLDERS (PDF : 17kb)
Latest news
Advertisement
Hot News 
CELYAD : Announces Results for the CHART-1 Phase III Clinical Trial Evaluating C-Cure® Cell Therapy
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regulus Therapeutics Inc. - RGLS
CARPETRIGHT : Annual Profit Up But Cautious On Outlook After Brexit Vote
XENCOR : Announces Strategic Collaboration for Bispecific Programs, including XmAb 14045 and XmAb 13676
TELADOC, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Most Read News
09:15p VOLKSWAGEN : VW agrees to buy back diesel vehicles, fund clean air efforts
08:31p Oil prices rise on Norway strike threat; Brexit shock fades
Most recommended articles
11:32p SUZUKI MOTOR : Motors says Brexit to have 'major' impact on earnings
11:21p Asia stocks bounce, bonds benefit from the unknown
10:44p SONY : lifts revenue target for games, but cuts outlook for image sensors
10:22pDJOil Edges Higher on Strike Threat; Brexit Effects Abate
10:16pDJPG&E : California Officials Let PG&E Use Land for Diablo Canyon Nuclear Plant Until 2025